SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-013260
Filing Date
2019-03-07
Accepted
2019-03-07 07:53:15
Documents
3
Period of Report
2019-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-6059_18k.htm 8-K 27793
2 EX-99.1 a19-6059_1ex99d1.htm EX-99.1 91968
3 GRAPHIC g60591mm01i001.jpg GRAPHIC 3934
  Complete submission text file 0001104659-19-013260.txt   126636
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38492 | Film No.: 19664343
SIC: 2834 Pharmaceutical Preparations